Unverified50% confidenceFactExact time
Theranos exploited the regulatory exemption for laboratory-developed tests (LDTs), packaging its commercialized blood testing services as LDTs to bypass FDA approval.
1
Sources
50%
Confidence
Long-term
Relevance
9/9/2026
First Seen
Sources
Related Entities
Cite This Claim
Stable URI
https://kongchang.com/claim/882816API
curl https://kongchang.com/api/v1/knowledge/claims/882816MCP
get_claim(id=882816)